IMA401 is a T cell receptor (TCR)-based next-generation bispecific T cell engaging receptor (TCER) t...
MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial
IMA401 is a T cell receptor (TCR)-based next-generation bispecific T cell engaging receptor (TCER) targeting an HLA-A*02:01-presented peptide derived from...
Author: Nature
Read Original Article